“…Binding of heparin to hATIII induces a conformational change in the hATIII molecule (Einarsson and Andersson, 1977;Fish and Björk, 1979;Olson et al, 1981;Li et al, 1976;Rosenberg and Damus, 1973;Villaneuva and Danishefsky, 1977), which accelerates the reaction between hATIII and thrombin or tightens the heparinantithrombin III complex (Olson et al, 1981;Peterson and Blackburn, 1987). The cDNA for hATIII was cloned (Bock et al, 1982;Chandra et al, 1983;Colau et al, 1985;Prochownik et al, 1983) and stable expression in CHO cells (Wasley et al, 1987;Zettlmeissl et al, 1987) yielded biologically active hATIII (Zettlmeissl et al, 1987). hATIII produced in CHO cells is very similar to plasma hATIII, but shows an altered glycosylation pattern (Zettlmeissl et al, 1989) and affinity for heparin (Björk et al, 1992).…”